rejuvant life tabs

Hormone producing organoids to halt age-related disease

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

JangoBio claims a scientific breakthrough in developing sustainable stem-cell based organoids for hormone restoration.

Having recently closed a $2m seed round, researchers at JangoBio’s Wisconsin laboratory announced that they have successfully created organoids to emulate the production of ovarian and testicular hormones. They claim their approach has the capacity to regenerate and replace hormone-producing tissues and reverse the natural decline of sex hormones that occurs with age.

“The development of hormone-producing organoids paves the way for use in humans and animals,” said Dr Craig Atwood, CEO. “JangoBio is rapidly moving towards testing of our organoid products in animal models.” [1]


Restoration of circulating hormone concentrations offers the benefits of preventing the symptoms of menopause and male andropause – potentially halting age-related disease and increasing the healthy lifespan of humans and animals.


 

Restoration of circulating hormone concentrations offers the benefits of preventing the symptoms of menopause and male andropause – potentially halting age-related disease and increasing the healthy lifespan of humans and animals. The JangoBio team think that implanted organoids may well be the first cell-based therapies to fully reverse hormonal decline and the associated age-related diseases, claiming that organoid-based hormone therapies are superior to traditional single hormone-based therapies, allowing restoration of all hormones produced by the ovaries and testes.

Elevant

Beginning with companion animals, treatments will be administered by veterinary clinics throughout North America. The next phase of development will introduce these therapies into human clinical trials.

Elevant

JangoBio utilises regenerative stem-cell based precision medicine to restore circulating hormone balance required for optimal health and Longevity.

[1] https://bit.ly/39W2YOB

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Can CRISPR be used to diagnose aging?

Irina Conboy talks CRISPR and how the gene-editing tech may have a significant role to play in diagnostics. In the first article from our interview...

Young blood to old – where do the answers to aging lie?

Irina Conboy talks parabiosis, plasma dilution, and why young blood may not hold the all answers. When it comes to scientific research in the world...

Enzymes show interconnectivity of Parkinson’s and diabetes

Parkinson's and Type 2 diabetes share a key element that drives disease – and metformin might help both. Parkin is a protein coded by the...

Building a longevity biotech from scratch

Alchemab exec talks company creation and how antibody therapeutics may play a role in longevity biotech. Last week, we covered Alchemab Therapeutics’ $82 million Series...

Cellino: longevity powered by AI, stem cells & democracy

From a serendipitous meeting of minds to laser-enabled precision, Cellino is leveraging AI and pluripotent stem cells for longevity. We speak to CEO and...
Supps report ad middle